Shopping Cart
- Remove All
- Your shopping cart is currently empty
ABT-670 is a selective agonist of dopamine D4 receptor. For human D4, ferret D4, and rat D4, the EC50 values are 89 nM, 160 nM, and 93 nM , respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 8-10 weeks | |
50 mg | $1,980 | 8-10 weeks | |
100 mg | $2,500 | 8-10 weeks |
Description | ABT-670 is a selective agonist of dopamine D4 receptor. For human D4, ferret D4, and rat D4, the EC50 values are 89 nM, 160 nM, and 93 nM , respectively. |
Targets&IC50 | D4 (rat):93 nM(EC50), D4 (Ferret):160 nM(EC50), D4 (human):(EC50)89 nM |
In vitro | ABT-670 is a selective D4 agonist. For human?D4, ferret?D4, and rat?D4, the EC50s values are 89 nM, 160 nM, and 93 nM, respectively[1]. |
In vivo | ABT-670, at a dosage of 0.1 μmol/kg, significantly promotes a high incidence (75%) of erections in male rats, demonstrating robust efficacy. Furthermore, it displays exceptional oral bioavailability across multiple species—rat (68%), dog (85%), and monkey (91%)—while maintaining comparable efficacy, safety, and tolerability[1]. |
Molecular Weight | 325.4 |
Formula | C19H23N3O2 |
Cas No. | 630119-43-6 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.